Literature DB >> 23295045

The pulmonologist's point of view on lung infiltrates in haematological malignancies.

A Bergeron1.   

Abstract

In haematological malignancies, the development of lung disease is a common source of significant morbidity and mortality for this population of patients. There is a wide range of infectious and non-infectious aetiologies that can be responsible for such complications. It is a major challenge to make an early diagnosis of aetiology in order to choose the most suitable treatment. Computed tomography (CT) of the chest has undeniably become a crucial tool in diagnosing these cases of lung disease. Although it is not possible to make a definitive diagnosis of aetiology based solely on analysing CT scan findings in these complex patients, there are some abnormalities that are highly suspicious for particular diagnoses. CT, therefore, allows the clinician to put forward and prioritise possible diagnoses that may then be considered in view of clinical information and laboratory study results. There must be multidisciplinary involvement in the management of lung disease patients and there must be an ongoing dialogue between the radiologist and the clinician.
Copyright © 2012 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chest CT scan; Haematological malignancy; Lung disease

Mesh:

Year:  2013        PMID: 23295045     DOI: 10.1016/j.diii.2012.12.004

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  2 in total

Review 1.  Diagnostic Evaluation of Pulmonary Abnormalities in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation.

Authors:  Bianca Harris; Alexander I Geyer
Journal:  Clin Chest Med       Date:  2017-06       Impact factor: 2.878

2.  Human metapneumovirus pneumonia in patients with hematological malignancies.

Authors:  Cendrine Godet; Jérôme Le Goff; Agnès Beby-Defaux; Marie Robin; Emmanuel Raffoux; Bertrand Arnulf; France Roblot; Jean Pierre Frat; Natacha Maillard; Abdellatif Tazi; Anne Bergeron
Journal:  J Clin Virol       Date:  2014-09-01       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.